Clinical trial
Gemcitabine, Cisplatin, and Dexamethasone in Treating Patients With Relapsed or…
NCT00090909 · Jonsson Comprehensive Cancer Center, Other · Completed
Key facts
| NCT number | NCT00090909 |
|---|---|
| Title | Gemcitabine, Cisplatin, and Dexamethasone in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma |
| Official title | A Phase II Study Of Gemcitabine, Cisplatin, and Dexamethasone In Patients With Relapsed Or Refractory Hodgkin Lymphoma |
| Lead sponsor | Jonsson Comprehensive Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Drug |
| Interventions | cisplatin, dexamethasone, gemcitabine hydrochloride |
| Enrollment | 1 |
| Start date | Jun 1, 2003 |
| Primary completion | Mar 1, 2005 |
| First posted | Sep 8, 2004 |
| Last update posted | Jan 8, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: